Zweig DiMenna Associates LLC Makes New Investment in SPDR S&P Biotech ETF $XBI

Zweig DiMenna Associates LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 110,700 shares of the exchange traded fund’s stock, valued at approximately $13,498,000.

Several other hedge funds also recently modified their holdings of the company. Fort Sheridan Advisors LLC boosted its stake in shares of SPDR S&P Biotech ETF by 6.1% during the 4th quarter. Fort Sheridan Advisors LLC now owns 5,224 shares of the exchange traded fund’s stock worth $637,000 after purchasing an additional 300 shares during the last quarter. JTC Employer Solutions Trustee Ltd boosted its stake in shares of SPDR S&P Biotech ETF by 5,367.4% during the 4th quarter. JTC Employer Solutions Trustee Ltd now owns 84,745 shares of the exchange traded fund’s stock worth $10,335,000 after purchasing an additional 83,195 shares during the last quarter. Foundations Investment Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $280,000. Huntington National Bank boosted its stake in shares of SPDR S&P Biotech ETF by 72,900.0% during the 4th quarter. Huntington National Bank now owns 730 shares of the exchange traded fund’s stock worth $89,000 after purchasing an additional 729 shares during the last quarter. Finally, IPG Investment Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $202,000.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $136.69 on Friday. The firm’s 50-day moving average is $130.99 and its two-hundred day moving average is $125.94. SPDR S&P Biotech ETF has a 12-month low of $78.06 and a 12-month high of $139.19. The stock has a market capitalization of $8.72 billion, a P/E ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.